Ranbaxy Loses Bid to Block Other Firms' Nexium, Valcyte Generic Products
March 2, 2015
Dana Elfin
Bloomberg BNA Pharmaceutical Law & Industry Report
Axinn Partner Chad Landmon was quoted in the Bloomberg BNA Pharmaceutical Law & Industry Report article, "Ranbaxy Loses Bid to Block Other Firms' Nexium, Valcyte Generic Products."
Click here to access the Bloomberg BNA Pharmaceutical Law & Industry Report. A subscription is required.